GY48LS6

Кеймбридж
[ ]
Традиционная китайская медицина (Traditional Chinese Medicine)
Международное непатентованное наименование Традиционная китайская медицина (Traditional Chinese Medicine)
Торговое наименование -
Производитель, страна -
Лекарственная форма herb capsules
Публикации COVID-19

Fui Fui LemFernandes Opook, et al. Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic scoping review. May 04, 2020. DOI: 10.1101/2020.04.10.20060376. 

 

Dan ZhangBing Zhang, et al. The Clinical Benefits of Chinese Patent Medicines Against COVID-19 Based on Current Evidence. Pharmacol Res. 2020 May 4;104882. DOI: 10.1016/j.phrs.2020.104882.

 

Xia RenXin-Xin Shao, et al. Identifying Potential Treatments of COVID-19 From Traditional Chinese Medicine (TCM) by Using a Data-Driven Approach. J Ethnopharmacol. 2020 May 3;112932. DOI: 10.1016/j.jep.2020.112932.

 

Jun-Ling RenAi-Hua ZhangXi-Jun Wang. Traditional Chinese Medicine for COVID-19 Treatment. Pharmacol Res. 2020 May;155:104743. DOI: 10.1016/j.phrs.2020.104743.

 

Erdan LuoDaiyan Zhang, et al. Treatment Efficacy Analysis of Traditional Chinese Medicine for Novel Coronavirus Pneumonia (COVID-19): An Empirical Study From Wuhan, Hubei Province, China. Chin Med. 2020 Apr 15;15:34. DOI: 10.1186/s13020-020-00317-x. 

 

Yang Yang, Md Sahidul Islam, Jin Wang, Yuan Li, Xin Chen. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. Int J Biol Sci 2020; 16(10):1708-1717. DOI:10.7150/ijbs.45538.

 

Ruijin QiuChen Zhao, et al. Core Outcome Set for Clinical Trials of COVID-19 based on Traditional Chinese and Western Medicine. April 07, 2020. DOI: 10.1101/2020.03.23.20041533.

 

Ruijin QiuXuxu Wei, et al. Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review. March 08, 2020. DOI: 10.1101/2020.03.04.20031401. 

 

Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine. Volume 18, Issue 2, March 2020, Pages 87-88. DOI: 10.1016/j.joim.2020.02.004.

Клинические исследования
1.
Название протокола Clinical Trial on Regularity of TCM Syndrome and Differentiation Treatment of COVID-19 in Jiangsu Province
Дата начала и окончания КИ May 2020
Название организации, проводящей КИ Jiangsu Famous Medical Technology Co., Ltd.
Страны China
Фаза -
Кол-во пациентов 340
2.
Название протокола Clinical efficacy of TCM syndrome differentiation in the treatment of severe/critical type of novel coronavirus pneumonia (COVID-19): a prospective, observational, one-arm clinical study
Дата начала и окончания КИ March 1, 2020 - December 31, 2020
Название организации, проводящей КИ Hospital of Chengdu University of Traditional Chinese Medicine
Страны China
Фаза -
Кол-во пациентов 60
3.
Название протокола Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19)
Дата начала и окончания КИ March 1, 2020 - December 31, 2020
Название организации, проводящей КИ Beijing University of Chinese Medicine
Страны China
Кол-во пациентов 150
4.
Название протокола A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Traditional Chinese Medicine as an Adjuvant Treatment for Patients With Severe COVID-19
Дата начала и окончания КИ March 2020 - April 2020
Название организации, проводящей КИ Xiyuan Hospital of China Academy of Chinese Medical Sciences
Страны China
Фаза III
Кол-во пациентов 50
5.
Название протокола Clinical investigation and reseach on TCM syndrome of COVID-19
Дата начала и окончания КИ February 28, 2020 - June 30, 2021
Название организации, проводящей КИ First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Страны China
Кол-во пациентов 160
6.
Название протокола Key techniques of combination therapy of Novel Coronavirus Pneumonia (COVID-19) - Study on TCM symptoms and treatment law
Дата начала и окончания КИ February 28, 2020 - July 30, 2020
Название организации, проводящей КИ Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Страны China
Фаза -
Кол-во пациентов 950
7.
Название протокола Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19)
Дата начала и окончания КИ February 15, 2020 - March 30, 2020
Название организации, проводящей КИ Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital
Страны China
Фаза -
Кол-во пациентов 120
8.
Название протокола TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control
Дата начала и окончания КИ February 3, 2020 - May 1, 2020
Название организации, проводящей КИ Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Страны China
Фаза -
Кол-во пациентов 3000
9.
Название протокола An epidemiology study for TCM syndrome of novel coronavirus pneumonia (COVID-19)
Дата начала и окончания КИ February 2, 2020 - December 1, 2020
Название организации, проводящей КИ Hubei Integrated Hospital of Traditional Chinese and Western Medicine
Страны China
Фаза -
Кол-во пациентов 600
10.
Название протокола A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19)
Дата начала и окончания КИ February 1, 2020 - December 1, 2021
Название организации, проводящей КИ Beijing hospital of Traditional Chinese medicine; Hubei integrated traditional Chinese and Western Medicine Hospital
Страны China
Фаза IV
Кол-во пациентов 100
11.
Название протокола Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19)
Дата начала и окончания КИ February 1, 2020 - June 30, 2021
Название организации, проводящей КИ The First Affiliated Hospital of He'nan University of Chinese Medicine
Страны China
Кол-во пациентов 100
12.
Название протокола Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19)
Дата начала и окончания КИ February 1, 2020 - December 31, 2020
Название организации, проводящей КИ The First Affiliated Hospital of He'nan University of Chinese Medicine
Страны China
Фаза -
Кол-во пациентов 200
13.
Название протокола Effects of Traditional Chinese Medicines (TCMs) on Patients With COVID-19 Infection: A Perspective, Open-labeled, Randomized, Controlled Trial
Дата начала и окончания КИ January 22, 2020 - January 22, 2021
Название организации, проводящей КИ Beijing 302 Hospital
Страны China
Фаза -
Кол-во пациентов 150